These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 15251828)

  • 1. Assessment of therapy with continuous subcutaneous insulin infusion in an academic diabetes clinic.
    Rudolph JW; Hirsch IB
    Endocr Pract; 2002; 8(6):401-5. PubMed ID: 15251828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Budget impact of continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes who experience severe recurrent hypoglycemic episodes in Spain.
    Giménez M; Elías I; Álvarez M; Quirós C; Conget I
    Endocrinol Diabetes Nutr; 2017; 64(7):377-383. PubMed ID: 28745609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effects of continuous subcutaneous insulin infusion in older patients with long-standing type 1 diabetes.
    Rizvi AA; Petry R; Arnold MB; Chakraborty M
    Endocr Pract; 2001; 7(5):364-9. PubMed ID: 11585372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous subcutaneous insulin infusion vs modern multiple injection regimens in type 1 diabetes: an updated meta-analysis of randomized clinical trials.
    Pala L; Dicembrini I; Mannucci E
    Acta Diabetol; 2019 Sep; 56(9):973-980. PubMed ID: 30945047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous Subcutaneous Insulin Infusion in Adult Type 1 Diabetes Mellitus Patients: Results from a Public Health System.
    Moreno-Fernandez J; Gomez FJ; Pinés P; González J; López J; López LM; Blanco B; Roa C; Herranz S; Muñoz-Rodríguez JR
    Diabetes Technol Ther; 2019 Aug; 21(8):440-447. PubMed ID: 31199682
    [No Abstract]   [Full Text] [Related]  

  • 6. Fear of hypoglycemia in type 1 diabetes managed by continuous subcutaneous insulin infusion: is it associated with poor glycemic control?
    Nixon R; Pickup JC
    Diabetes Technol Ther; 2011 Feb; 13(2):93-8. PubMed ID: 21284474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with adherence to continuous subcutaneous insulin infusion in pediatric diabetes.
    Babar GS; Ali O; Parton EA; Hoffmann RG; Alemzadeh R
    Diabetes Technol Ther; 2009 Mar; 11(3):131-7. PubMed ID: 19216689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term metabolic effects of continuous subcutaneous insulin infusion therapy in type 1 diabetes.
    Cohen ND; Hong ES; Van Drie C; Balkau B; Shaw J
    Diabetes Technol Ther; 2013 Jul; 15(7):544-9. PubMed ID: 23617252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) using continuous glucose monitoring in metabolically optimized type 1 diabetes patients: A randomized open-labelled parallel study.
    Ruiz-de-Adana MS; Dominguez-Lopez ME; Gonzalez-Molero I; Machado A; Martin V; Cardona I; de-la-Higuera M; Tapia MJ; Soriguer F; Anarte MT; Rojo-Martínez G
    Med Clin (Barc); 2016 Mar; 146(6):239-46. PubMed ID: 26656958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between continuous subcutaneous insulin infusion and multiple insulin injection therapy in type 1 diabetes mellitus: 18-month follow-up.
    Hissa MN; Hissa AS; Bruin VM; Fredrickson LP
    Endocr Pract; 2002; 8(6):411-6. PubMed ID: 15251830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does the timing of insulin pump therapy initiation after type 1 diabetes onset have an impact on glycemic control?
    Shalitin S; Lahav-Ritte T; Lebenthal Y; Devries L; Phillip M
    Diabetes Technol Ther; 2012 May; 14(5):389-97. PubMed ID: 22283639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The Impact of Prolonged Use of Continuous Subcutaneous Insulin Infusion in the Control of Type-1 Diabetes].
    Azevedo S; Saraiva J; Caramelo F; Fadiga L; Barros L; Baptista C; Melo M; Gomes L; Carrilho F
    Acta Med Port; 2019 Feb; 32(1):17-24. PubMed ID: 30753799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the effectiveness of long-term insulin pump therapy using a combined goal of HbA
    Quirós C; Viñals C; Giménez M; Roca D; Conget I
    Endocrinol Diabetes Nutr (Engl Ed); 2019 Nov; 66(9):534-539. PubMed ID: 31133475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens using insulin lispro in type 1 diabetic patients on intensified treatment: a randomized study. The Study Group for the Development of Pump Therapy in Diabetes.
    Hanaire-Broutin H; Melki V; Bessières-Lacombe S; Tauber JP
    Diabetes Care; 2000 Sep; 23(9):1232-5. PubMed ID: 10977011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of anxiety and depression on patients within a large type 1 diabetes insulin pump population. An observational study.
    Grant P; Dworakowska D; DeZoysa N; Barnes D
    Diabetes Metab; 2013 Oct; 39(5):439-44. PubMed ID: 24076359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous subcutaneous insulin infusion versus multiple daily injections: the impact of baseline A1c.
    Retnakaran R; Hochman J; DeVries JH; Hanaire-Broutin H; Heine RJ; Melki V; Zinman B
    Diabetes Care; 2004 Nov; 27(11):2590-6. PubMed ID: 15504991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized controlled trial of insulin pump therapy in young children with type 1 diabetes.
    Fox LA; Buckloh LM; Smith SD; Wysocki T; Mauras N
    Diabetes Care; 2005 Jun; 28(6):1277-81. PubMed ID: 15920039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of multiple daily insulin therapy with continuous subcutaneous insulin infusion therapy in adolescents with type 1 diabetes mellitus: a single-center experience from Turkey.
    Abaci A; Atas A; Unuvar T; Demir K; Bober E; Büyükgebiz A
    J Pediatr Endocrinol Metab; 2009 Jun; 22(6):539-45. PubMed ID: 19694201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) in type 1 diabetes: a randomized open parallel multicenter study.
    Bolli GB; Kerr D; Thomas R; Torlone E; Sola-Gazagnes A; Vitacolonna E; Selam JL; Home PD
    Diabetes Care; 2009 Jul; 32(7):1170-6. PubMed ID: 19389820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experiences and real life management of insulin pump therapy in adults with type 1 diabetes.
    Quirós C; Jansà M; Viñals C; Giménez M; Roca D; Escarrabill J; Garcia F; Pérez S; Conget I
    Endocrinol Diabetes Nutr (Engl Ed); 2019 Feb; 66(2):117-123. PubMed ID: 30076125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.